Herbalife (HLF) EBITDA Margin (2009 - 2026)

Herbalife has disclosed EBITDA Margin across 18 years of filings, most recently posting 10.51% for Q1 2026.

• EBITDA Margin for Q1 2026 came in at 10.51%, up 46.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 9.67% (up 85.0% YoY), and the FY2025 annual result was 9.55%, up 182.0% from the prior year.
• EBITDA Margin came in at 10.51% for Q1 2026 at Herbalife, up from 7.78% in the prior quarter.
• In the past five years, EBITDA Margin ranged from a high of 11.46% in Q1 2022 to a low of 4.59% in Q4 2023.
• The 5-year median for EBITDA Margin is 9.39% (2023), against an average of 8.78%.
• Across the five-year window, EBITDA Margin soared 4789 bps in 2022 and plunged 583 bps in 2023, its largest moves.
• Herbalife's EBITDA Margin stood at 7.53% in 2022, then slumped by 39 bps to 4.59% in 2023, then surged by 92 bps to 8.82% in 2024, then fell by 12 bps to 7.78% in 2025, then soared by 35 bps to 10.51% in 2026.
• The last three EBITDA Margin figures came in at 10.51% (Q1 2026), 7.78% (Q4 2025), and 9.88% (Q3 2025), per Business Quant data.